TrialAntimicrobial agents and chemotherapy2008

Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition.

Signe Fransen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.